Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma with ESR1 gene amplification
-
Published:2024-08
Issue:
Volume:54
Page:101426
-
ISSN:2352-5789
-
Container-title:Gynecologic Oncology Reports
-
language:en
-
Short-container-title:Gynecologic Oncology Reports
Author:
Soiffer Jenny L.ORCID,
Fife Alexander J.,
Gadad Shrikanth S.,
Laurini Javier A.,
Elvin Julia A.,
Isani Sara S.,
Lin Ken Y.